Wed, September 26, 2012
Tue, September 25, 2012
Mon, September 24, 2012
Sun, September 23, 2012
Fri, September 21, 2012
Thu, September 20, 2012
Wed, September 19, 2012
Tue, September 18, 2012
Mon, September 17, 2012
Sun, September 16, 2012
Fri, September 14, 2012
Thu, September 13, 2012
Wed, September 12, 2012
Tue, September 11, 2012
Mon, September 10, 2012

The Law Firm of Levi &;; Korsinsky Notifies Investors With Losses on Their Investment in Vertex Pharmaceuticals Incor


//health-fitness.news-articles.net/content/2012/ .. -investment-in-vertex-pharmaceuticals-incor.html
Published in Health and Fitness on Wednesday, September 19th 2012 at 12:46 GMT by Market Wire   Print publication without navigation


September 19, 2012 15:17 ET

The Law Firm of Levi & Korsinsky Notifies Investors With Losses on Their Investment in Vertex Pharmaceuticals Incorporated of Class Action Lawsuit and the Deadline of November 5, 2012 to Seek a Lead Plaintiff Position

NEW YORK, NY--(Marketwire - Sep 19, 2012) -  Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of Massachusetts on behalf of investors who acquired Vertex Pharmaceuticals Incorporated ("Vertex" or the "Company") (NASDAQ: [ VRTX ]) securities between May 7, 2012 and June 27, 2012.

For more information, click here: [ http://zlk.9nl.com/vertex-pharmaceuticals-vertex ]. There is no cost or obligation to you.

On May 7, 2012, Vertex issued a press release claiming that patients who received two of its drugs during clinical trials showed significant improvement in their lung functions. Between May 7, 2012 and May 25, 2012, certain Vertex officers and directors sold over $22 million of their personally owned shares. Then, on May 29, 2012, Vertex issued a series of press releases in which it acknowledged that the results from its clinical trials were not as positive as previously indicated. These results were further restated on June 28, 2012. Upon this news, Vertex stock fell from a close of $61.11 on June 27, 2012, to a close of $51.18 on June 28, 2012.

If you suffered a loss in Vertex you have until November 5, 2012 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. To obtain additional information, contact Joseph E. Levi, Esq. either via email at [ jlevi@zlk.com ] or by telephone at (877) 363-5972, or visit [ http://zlk.9nl.com/vertex-pharmaceuticals-vertex ].

Levi & Korsinsky is a national firm with offices in New York and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.



Publication Contributing Sources